EssilorLuxottica Announces Three Strategic Partnerships to Advance Vision Health Ecosystem at CIIE

ShanghaiNovember 7, 2022PR Newswire -- At the fifth China International Import Expo, EssilorLuxottica, a global leader in vision care and eyewear manufacturing, announced three strategic collaborations with the Shanghai Eye Disease Prevention and Treatment Center, the National Quality Supervision and Inspection Center for Eyeglass, Glass, and Enamel Products, and Star Horizon, the parent company of Baodao Eyewear. These partnerships will focus on three key areas: myopia prevention and control, ophthalmic optics quality inspection standards, and photochromic lenses and light management. Through in-depth exchanges and cooperation, the initiatives aim to continuously expand the vision health ecosystem and promote the implementation of the optical industry's "people-goods-place" upgrading concept.

Lin Guoliang, President of Professional Vision Health Business at EssilorLuxottica Greater China, stated: "As an advocate and leader in the vision health ecosystem, EssilorLuxottica has been committed to exploring innovative collaboration models with government, enterprises, medical professionals, research institutions, media, and other ecosystem partners over the years. In light of the ongoing severity of myopia prevention and control, our comprehensive cooperation with the National Clinical Research Center for Ocular Diseases and Shanghai Eye Disease Prevention, which focuses on clinical research, standardized services, and public education, will further support the implementation of myopia prevention and control solutions. Regarding light management, the co-branded photochromic lenses launched in collaboration with Star Optical will promote the popularity of this category in the Chinese market and enhance the light management experience for Chinese consumers. The long-term development of the industry relies on the promotion and standardization of new technologies. Through international exchange and cooperation with the Shanghai Institute of Optics and Fine Mechanics, we hope to jointly promote the standardized development of China's optometry and eyewear industry. Moving forward, we look forward to more partners joining us to advance the iterative upgrade of the optometry industry and collectively safeguard the vision health of the Chinese people."

Joining Hands with the National Clinical Medical Center for Ocular Diseases and Shanghai Eye Prevention to Build an Integrated Myopia Prevention and Control Model

In Response to the Severe Situation of High Incidence and Early Onset of Myopia Among Chinese Children and Adolescents, EssilorLuxottica Partners with the National Clinical Research Center for Ocular Diseases and Shanghai Eye Disease Prevention and Treatment Center on a Strategic Cooperation for Integrated Myopia Prevention and Control, Promoting the Implementation of Solutions for Adolescent Myopia Management. According to the agreement, both parties will benchmark against international brands and launch the clinical testing project for Essilor’s first automatic computer optometry biometer. Additionally, they will share professional educational resources to further standardize myopia prevention protocols and the fitting process. At the consumer outreach level, both parties will upgrade the "Bright Eyes Visual Health Platform" of the Shanghai Eye Disease Prevention and Treatment Center, conduct public education, and enhance awareness of eye care and protection.

Professor Xu Xun, Director of the National Clinical Research Center for Ocular Diseases and Director of the Shanghai Children and Adolescents Myopia Prevention and Control Technology Center, stated regarding this collaboration: "Myopia among children and adolescents has become a leading cause of vision impairment in China, significantly impacting their physical and mental health. Over the years, we have emphasized both 'prevention' and 'treatment,' striving to create an innovative model for myopia prevention and control among children and adolescents. We are delighted to partner with EssilorLuxottica, a leader in the optical industry. Leveraging our extensive experience in myopia prevention and control for children and adolescents, we will explore efficient, scientific, and personalized solutions across various aspects of myopia management to reduce the incidence of myopia and support the achievement of national myopia prevention and control goals."

Professor Zou Haidong, Director of the Shanghai Eye Disease Prevention and Treatment Center and Vice President of the Shanghai First People's Hospital, stated: "The annual compound growth rate of ophthalmic diagnosis and treatment in China has maintained a high growth rate for many years, with myopia being one of the chronic eye diseases with the highest prevalence. As one of the locations of the National Clinical Medical Research Center for Ophthalmology, Shanghai is actively exploring a new 'Shanghai Model' that integrates myopia prevention and treatment, including establishing China’s first million-level refractive development archive for children, initiating the 'Basking in the Sunlight' science popularization campaign to prevent myopia, and developing the Ming眸 APP and intelligent outdoor activity monitoring bracelets for children. This integrated strategic signing is another measure in our continued efforts to advance myopia prevention and control, ensuring the eye health of children and adolescents."

As the leader of the clinical testing project for Essilor's automatic computer optometry biometer, Associate Professor He Xiangui, Director of the Clinical Research Center of Shanghai Eye Disease Prevention and Treatment Center and Director of the Office of Shanghai Children and Adolescents Myopia Prevention and Control Technology Center, stated: "The 2021 updated version of the National Health Commission’s myopia prevention and control appropriate technology guidelines suggests that regions with suitable conditions are encouraged to include axial length and corneal curvature measurements. We will scientifically evaluate the accuracy, repeatability, and work efficiency of biometers suitable for large-scale population screening, providing precise and efficient equipment for myopia prevention and control management, and promoting public awareness of the necessity of axial length measurement."

EssilorLuxottica Partners with the National Clinical Research Center for Ocular Diseases and Shanghai Eye Disease Prevention and Treatment Center to Sign a Strategic Cooperation Agreement on Myopia Prevention and Control

Collaborate with StarVision Group, the parent company of BaoDao Eyewear, to meet consumers' light protection management needs

EssilorLuxottica and Star Vision Group, the parent company of Bao Dao Eyewear, on photochromic lenses and 360DegreeLight Protection Management Signs Three-Year Strategic Cooperation to Bring Chinese Consumers a High-Quality Photochromic Lens Experience While Jointly Raising Awareness and Attention to the Light Protection Management Category. As a high-tech lens technology under EssilorLuxottica Group, Transitions® Intelligent Light-Adaptive Lenses can intelligently adapt to different light conditions by switching between indoor and outdoor environments, providing color-changing protection for users. This offers an enhanced visual experience and protection with continuously improving visual comfort and light protection, blocking over 99% of UVA and UVB rays. During the three-year strategic cooperation, S@P, a lens brand under Starvision, will collaborate with Transitions to launch the co-branded S@P Transitions product series, offering consumers products that better meet their needs and are more price competitive. The two parties will also utilize over 1,100 Baodao Eyewear stores as promotional platforms to educate and promote light protection management to more consumers in China.DegreeLight Protection Management Concept. This is another significant business collaboration between EssilorLuxottica and Star Vision World following the signing of an equipment procurement and strategic cooperation agreement during the 2020 CIIE.

Wang Zhimin, Chairman of Star Vision Group, stated: "As consumers' awareness of UV protection increases, the photochromic lens category, which combines vision correction and light protection, offers a convenient and stylish choice. EssilorLuxottica's Transitions is a leader in the photochromic lens field. By leveraging the technical advantages of Transitions and the distribution network of Baodao Eyewear under Star Vision Group, we hope to better meet the growing demand for light protection management among Chinese consumers."

EssilorLuxottica Collaborates with Star Vision Group, the Parent Company of Baodao Optometry, on a Three-Year Strategic Partnership for Photochromic Lenses and 360-Degree Light Protection Management

Jointly with Botang, Promote the Standardized Development of Optometric Technology

A sustainable market requires norms and standards as its cornerstone. During the CIIE, EssilorLuxottica and the National Quality Inspection and Testing Center for Glass and Enamel Products (referred to as the "Glass and Enamel Institute") signed a strategic cooperation agreement to jointly promote the standardization development of China's optometry industry. The Glass and Enamel Institute is the most authoritative quality inspection agency in the eyewear industry, leading the formulation of multiple national and industry standards in the eyewear field. Over the years, EssilorLuxottica and the Glass and Enamel Institute have engaged in close and fruitful cooperation, promoting and standardizing a series of new technologies. Currently, standards for micro-structured lenses, progressive lenses, and assembled progressive glasses are all in preparation and will be key focuses moving forward.

Ye Jiayi, Standing Vice Director of the National Quality Inspection and Testing Center for Glass, Enamel, and Eyewear Products, stated: "As one of the first national quality inspection institutions to pass the national accreditation review, the center has significant technical advantages in areas such as testing methods, standards research, and scientific development. It has developed numerous technical standards and has consistently remained at the forefront of standard-setting and testing. The collaboration with EssilorLuxottica helps meet the developmental needs of new technologies and applications in the optical field, improves testing standards for innovative products in the optometry industry, and further promotes the formulation and implementation of Chinese standards and international standards (ISO) in the field of ophthalmic optics, achieving standardized and orderly development in the optometry sector."

EssilorLuxottica Joins Hands with the National Quality Inspection and Testing Center for Glass, Enamel, and Eyewear Products to Sign a Strategic Cooperation Agreement